Rice Hall James & Associates’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-231,435
| Closed | -$7.39M | – | 279 |
|
|
2022
Q2 | $7.39M | Sell |
231,435
-152,317
| -40% | -$4.87M | 0.36% | 67 |
|
|
2022
Q1 | $13.3M | Buy |
383,752
+8,234
| +2% | +$285K | 0.53% | 55 |
|
|
2021
Q4 | $11M | Sell |
375,518
-34,263
| -8% | -$1M | 0.39% | 61 |
|
|
2021
Q3 | $10.4M | Buy |
409,781
+61,162
| +18% | +$1.56M | 0.39% | 67 |
|
|
2021
Q2 | $12.2M | Sell |
348,619
-50,686
| -13% | -$1.78M | 0.43% | 62 |
|
|
2021
Q1 | $16.3M | Buy |
399,305
+5,890
| +1% | +$240K | 0.53% | 54 |
|
|
2020
Q4 | $17M | Buy |
393,415
+72,488
| +23% | +$3.14M | 0.6% | 51 |
|
|
2020
Q3 | $17.7M | Buy |
320,927
+81,320
| +34% | +$4.48M | 0.71% | 43 |
|
|
2020
Q2 | $15.1M | Buy |
239,607
+17,352
| +8% | +$1.1M | 0.65% | 48 |
|
|
2020
Q1 | $11.4M | Sell |
222,255
-7,597
| -3% | -$388K | 0.63% | 48 |
|
|
2019
Q4 | $18.3M | Sell |
229,852
-5,910
| -3% | -$470K | 0.62% | 56 |
|
|
2019
Q3 | $11.4M | Buy |
235,762
+96,642
| +69% | +$4.69M | 0.41% | 94 |
|
|
2019
Q2 | $7.32M | Buy |
+139,120
| New | +$7.32M | 0.24% | 116 |
|